本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Rocket Pharmaceuticals, Inc.

3.41
-0.0200-0.58%
盤後3.490.0800+2.35%17:36 EDT
成交量:366.01萬
成交額:1,230.95萬
市值:3.74億
市盈率:-20.06
高:3.69
開:3.65
低:3.21
收:3.43
52周最高:5.45
52周最低:2.53
股本:1.10億
流通股本:8,496.03萬
量比:3.18
換手率:4.31%
股息:- -
股息率:- -
每股收益(TTM):-0.1700
每股收益(LYR):-2.0100
淨資產收益率:-4.77%
總資產收益率:-28.42%
市淨率:1.01
市盈率(LYR):-1.70

資料載入中...

2025/05/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/15

重要事件披露

Form 8-K - Current report
2025/05/08

重要事件披露

Form 8-K - Current report
2025/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/29

重要事件披露

Form 8-K - Current report
2025/04/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/07

重要事件披露

Form 8-K - Current report
2025/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities